Addition of bedtime lafutidine inhibits nocturnal acid-breakthrough and improves sleep quality in gastroesophageal reflux disease patients on esomeprazole: a randomized controlled trial
Abstract This study aims to evaluate the acid inhibition and clinical improvement of the addition of bedtime lafutidine to esomeprazole in comparison with esomeprazole only in Gastroesophageal reflux disease (GERD) patients with nocturnal symptoms. We conducted a single-center, observer-blinded, ran...
Saved in:
| Main Authors: | Dongke Wang, Ruohang He, Xiaohao Zhang, Chaofan Duan, Tao Bai, Junying Xu, Xuelian Xiang, Xiaohua Hou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-06767-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation between cough and gastroesophageal reflux in children
by: A. V. Burlutskaya, et al.
Published: (2022-09-01) -
Efficacy and Safety of Dual Delayed-Release Formulation of Esomeprazole in Patients with Gastroesophageal Reflux Disease: A Multicenter, Prospective, Observational Study
by: Hyun Lim, et al.
Published: (2025-01-01) -
Gastroesophageal Reflux Disease and Bronchial Asthma: Updated View on the Problem of Comorbidity
by: Hanych T.
Published: (2014-12-01) -
Pharmacodynamics of 2 dosages of orally administered esomeprazole in client‐owned, healthy dogs: A prospective, crossover study
by: Abby Ostronic, et al.
Published: (2024-11-01) -
Modern potentials of prokinetics in treatment of gastroesophageal reflux disease
by: A. A. Sheptulin, et al.
Published: (2010-11-01)